
Centerline Biomedical
Centerline Biomedical, Inc. is a spinoff of Cleveland Clinic headquartered in Cleveland, Ohio. The Company’s FDA-cleared technology platform, Intra-Operative Positioning System, IOPS®, enables improved visualization and navigation during endovascular procedures. IOPS combines electromagnetic navigation with 3D structural mapping and interactive guidance for real-time visualization of endovascular devices with high precision. The IOPS platform consists of a mobile cart powered by visualization software and proprietary, intelligent catheters and guidewires. The Company has recently received 510(K) clearance on its second-generation product with plans to release in late 2024.
Backed by a Series B investment from GE Healthcare and Cleveland Clinic Ventures in 2022, Centerline plans to kick of a Series C round in early 2025.